The European Center for Disease Prevention and Control (ECDC) announced on 16 November 2012 that antibiotic resistance remains a major public health issue in Europe, and is probably the result of inappropriate use of antibiotics in the community.
While issues with multiresistant MRSA (methicillin restistant Staph aureus) appear to have stabilized or declined in the EU, new concerns were raised about rising resistance of Klebsiella pneumoniae and Escherichia coli (E.coli) in more than one third of EU/EEA countries. In fact resistant strains represented between 25% and more than 60% of K.pneumoniae infections in some member states, leaving only last line antibiotics to treat these infections. And in some countries, resistance to carbapenem, a last line antibiotic, is also high – probably related to the increased usage of carbapenem due to resistance to first- and second-line treatments.
The organization urged the prudent use of antibiotics in humans and in vetinary practice to try to preserve the efficacy of the available antibiotics, while research into new treatments is ongoing.